BeyondSpring, Inc. - Ordinary Shares (BYSI): Price and Financial Metrics
BYSI Price/Volume Stats
| Current price | $1.70 | 52-week high | $2.97 |
| Prev. close | $1.68 | 52-week low | $0.98 |
| Day low | $1.65 | Volume | 8,700 |
| Day high | $1.70 | Avg. volume | 16,608 |
| 50-day MA | $1.56 | Dividend yield | N/A |
| 200-day MA | $1.80 | Market Cap | 68.54M |
BYSI Stock Price Chart Interactive Chart >
BeyondSpring, Inc. - Ordinary Shares (BYSI) Company Bio
BeyondSpring is a global clinical stage biopharmaceutical company developing innovative immuno-oncology cancer therapies. The co is advancing its lead asset, Plinabulin, into a Phase 3 clinical trial as a direct anticancer agent in non-small cell lung cancer and a Phase 2/3 clinical trial in the prevention of chemotherapy-induced Neutropenia.
BYSI Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BYSI Price Returns
| 1-mo | -4.49% |
| 3-mo | 1.80% |
| 6-mo | -1.16% |
| 1-year | -30.33% |
| 3-year | -21.30% |
| 5-year | -90.53% |
| YTD | 4.29% |
| 2024 | 81.11% |
| 2023 | -52.13% |
| 2022 | -58.50% |
| 2021 | -62.87% |
| 2020 | -21.29% |